Loading...
XSHE
002511
Market cap1.32bUSD
Jul 10, Last price  
6.98CNY
1D
0.58%
1Q
-16.81%
Jan 2017
-10.56%
IPO
4.61%
Name

C&S Paper Co Ltd

Chart & Performance

D1W1MN
XSHE:002511 chart
P/E
28.18
P/S
1.02
EPS
0.25
Div Yield, %
0.91%
Shrs. gr., 5y
-0.59%
Rev. gr., 5y
2.33%
Revenues
8.78b
+7.72%
1,236,306,1921,445,964,2391,618,693,2901,778,866,0451,856,258,1892,339,454,9722,501,718,7092,521,780,1702,958,976,6133,809,349,0714,638,349,5905,678,517,6226,634,914,3527,823,528,4169,149,870,4648,569,694,3599,800,950,7478,150,579,4908,779,846,944
Net income
319m
+312.80%
40,704,00850,836,390110,441,435108,879,42180,538,053158,908,628115,935,22967,502,20088,196,121260,416,586349,065,607406,993,189603,832,654905,889,088581,097,226349,971,122332,744,39877,181,583318,606,854
CFO
1.34b
P
18,570,872126,237,005219,992,99487,106,6720294,000,347216,366,627262,277,899429,180,402928,865,634585,437,434437,254,8441,360,374,901828,200,8621,319,579,606391,693,0121,241,989,817-349,311,8121,339,967,777
Dividend
Sep 24, 20250.063 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

C&S Paper Co.,Ltd, established in 1979 and headquartered in Zhongshan, China, operates as a manufacturer and seller of household paper goods throughout Mainland China. Its primary product line features an extensive selection of items such as paper rolls, facial tissues, coreless rolls, tissue handkerchiefs, wipes, personal care products, baby diapers, and cotton tissues. The company has also diversified its offerings to include medical devices, disposable medical products, disinfectants, and medical face masks. Furthermore, its business scope extends to general merchandise, kitchenware, sanitary ware, daily sundries, non-woven fabrics and their products, polymer materials and their products, wood pulp, and various baby products, in addition to providing warehousing services. C&S, Sun, and Dolemi are the brands under which its products are sold.
IPO date
Nov 25, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT